Core Viewpoint - The company, Sihuan Pharmaceutical Holdings Group Ltd (02096), has entered into a placement and subscription agreement to issue 121 million shares at a price of HKD 12.95 per share, aiming to raise approximately HKD 1.567 billion for research and operational needs [1] Group 1 - The seller, Simcere Pharmaceutical Holding Limited, plans to sell 121 million shares through the placement agent at a price of HKD 12.95 per share [1] - The total estimated proceeds from the subscription are approximately HKD 1.567 billion, with a net amount of about HKD 1.5535 billion [1] - Approximately 90% of the proceeds will be allocated for research and development expenses, while around 10% will be used for working capital and other general corporate purposes [1]
先声药业拟先旧后新配售1.21亿股股份 净筹约15.535亿港元